January 10, 2020 / 11:37 AM / 9 days ago

Eli Lilly to buy skin disease specialist Dermira for $1.1 billion

Jan 10 (Reuters) - Eli Lilly and Co said on Friday it would buy Dermira Inc for about $1.1 billion in cash to get access to the drugmaker’s skin disease drugs.

Lilly will pay $18.75 per share, or a 2.2% premium to Dermira’s last closing price, the companies said in a joint statement. (Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below